DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 119 filers reported holding DERMIRA INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,537,000 | +4557.6% | 101,387 | +1847.9% | 0.00% | – |
| Q3 2019 | $33,000 | -80.8% | 5,205 | -71.2% | 0.00% | – |
| Q2 2019 | $172,000 | -84.8% | 18,095 | -78.3% | 0.00% | -100.0% |
| Q1 2019 | $1,130,000 | +359.3% | 83,443 | +143.1% | 0.00% | +200.0% |
| Q4 2018 | $246,000 | -59.2% | 34,318 | -47.7% | 0.00% | -50.0% |
| Q2 2018 | $603,000 | +1059.6% | 65,622 | +893.5% | 0.00% | 0.0% |
| Q1 2018 | $52,000 | -84.1% | 6,605 | -43.8% | 0.00% | -85.7% |
| Q4 2017 | $327,000 | -37.8% | 11,759 | -39.7% | 0.01% | -33.3% |
| Q3 2017 | $526,000 | +491.0% | 19,505 | +532.7% | 0.02% | +425.0% |
| Q2 2017 | $89,000 | +217.9% | 3,083 | +269.2% | 0.00% | +300.0% |
| Q1 2017 | $28,000 | +1300.0% | 835 | +882.4% | 0.00% | – |
| Q4 2016 | $2,000 | -99.2% | 85 | -98.9% | 0.00% | -100.0% |
| Q3 2016 | $261,000 | -20.9% | 7,733 | -31.5% | 0.02% | -18.2% |
| Q2 2016 | $330,000 | – | 11,284 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,984,364 | $55,185,000 | 7.74% |
| NEA Management Company, LLC | 3,506,649 | $97,520,000 | 4.04% |
| Avoro Capital Advisors LLC | 1,520,000 | $42,271,000 | 2.74% |
| Iguana Healthcare Management, LLC | 100,000 | $2,781,000 | 1.81% |
| Abingworth LLP | 70,000 | $1,947,000 | 1.41% |
| DAFNA Capital Management LLC | 86,000 | $2,392,000 | 1.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $3,004,000 | 1.06% |
| Opaleye Management Inc. | 100,000 | $2,781,000 | 0.89% |
| New Leaf Venture Partners, L.L.C. | 61,109 | $1,699,000 | 0.80% |
| Ghost Tree Capital, LLC | 100,000 | $2,781,000 | 0.65% |